Newsroom

For Press Contact
media@integraconnect.com
Announcements
In The News Thought Leadership
Back

Trilaciclib Decreases Rates of High-Grade HAEs in ES-SCLC in RWS

Sep 12, 2023
Specialty Practices
Click here to read the original article at Targeted Oncology.